Expectations For The Connected Care Business In The Years Ahead
As we venture further into 2023, Glooko CEO Russ Johannesson shares his perspective on the connected care trends in digital therapeutics, remote patient...
Diabetes company Glooko partners with insulin dosing app Hedia
Through a new partnership, the Hedia app, which provides bolus insulin dosing recommendations, will integrate with Glooko’s connected care platform,...
Glooko adds insulin dosing recommendations to diabetes management app with Hedia collab
In addition to gathering data from glucose monitors, insulin pumps, fitness trackers and other devices, Glooko’s diabetes management platform will offer...
The connected care horizon in 2023
2023 is expected to be a year of advancements in connected care supporting patients with chronic conditions and their care teams. Glooko CEO Russ Johannesson...
Smart Insulin Pens: How They Work, And Your Experiences of Using Them
Smart insulin pens are a recent advancement making an impact on people living with diabetes. These connected pens can be used by anyone with the chronic...
Sanofi boosts ‘connected insulin’ push with Glooko deal
Sanofi formed a partnership with Glooko to support its vision of insulin-based therapies connected with glucose monitoring devices that simplify blood...
Glooko, Sanofi partner on insulin pen connectivity
Glooko entered into a partnership with Sanofi to integrate a connected cap for smart insulin pens into its digital platform for people with diabetes and...
Glooko, Sanofi Partner for SoloStar Pen Connectivity with New Device SoloSmart
A new alliance between Glooko and Sanofi allows for visualization of connected pen data in the Glooko app that patients with diabetes can share with their...
Glooko picks up security certification for diabetes patient management platform
Glooko achieving ISO 27001 certification allows the digital health company to assure patients with diabetes and related chronic conditions that their health...
2023 Tech Trends: Why Digital Health Will Lead to Improved Patient Care
Wearable technologies that were built for fitness have evolved and now have greater diagnostic and medical uses. Glooko Chief Executive Officer Russ Johannesson...
Remote Patient Monitoring: It’s Easier Than You Think
Remote patient monitoring is likely to become as essential to healthcare as mobile phones are to modern life. Glooko Chief Commercial Officer Zach Henderson...
The Water’s Fine: Consider Jumping Into Remote Patient Monitoring
Glooko Chief Commercial Officer Zach Henderson shares the clinical and financial benefits of healthcare providers, health systems and payers leveraging...
Glooko AB Expands Academy Medical Education Program into Ireland
The expansion of Academy™, a free educational programme from Glooko and the Diabetes Technology Network/Association of British Clinical Diabetologists,...
Glooko Launches Diabetes Medical Education Academy in Ireland
Glooko announced, in partnership with the Diabetes Technology Network/Association of British Clinical Diabetologists, the expansion into Ireland of Academy™,...
Building Digital Platforms To Bridge Diabetes Care Gaps
Device-integrating digital health platforms, like Glooko, help bridge diabetes care gaps and enable patients to better manage their condition.
Medidata Announces Rapid Expansion of its Sensor Cloud Network with the Addition of 10 Health Technology Innovators
Medidata announced ten highly innovative organizations, including Glooko, have joined its groundbreaking Sensor Cloud Network. The company is making it...
PopHealth Week: Meet Glooko Chief Medical Officer Mark Clements, M.D., Ph.D.
Glooko Chief Medical Officer Mark Clements, M.D., Ph.D. discussed the impact of diabetes on public health in the U.S. and how digital health platforms...
Sharper data collection is key to better insurance CX
Glooko’s remote patient monitoring solution allows healthcare providers at Atrius Health to view vast quantities of patient data and monitor a patient’s...
THCB Spotlight: Russ Johannesson, CEO at Glooko
Glooko CEO Russ Johannesson brings Founder and Publisher Matthew Holt up to speed on how the connected care company has expanded globally, made strategic...
Spotlight On: Taking the friction out of diabetes management
At ATTD 2022, Glooko CEO Russ Johannessen shares insights with Executive Editor Tina Tan about how AI and other technologies can enable better and more...
Academy™: An Online Diabetes Educational Programme for Healthcare Professionals
Chair of the Diabetes Technology Network UK Dr. Pratik Choudhary outlines the development of Academy™, a free CPD accredited online educational programme,...
The 6 Factors of Success: How Digital Diabetes Management Solutions set an example for others
Successful digital diabetes platform vendors, like Glooko, are aware of the needs of healthcare providers and offer advanced population management solutions...
The 2022 HealthTech Brand Check
In an era of health fads and medical disinformation, building a business on evidence-led, authoritative information is more important than ever. Glooko...
Glooko’s Role in Revolutionizing Diabetes Data Usability
Diabetes technology and data sharing capabilities have come an incredibly long way, and Glooko has helped lead the way. This retrospective explores Glooko’s...
At-Home Digital Health Innovations Transforming Diabetes Care
Glooko Chief Medical Officer Mark Clements, M.D., Ph.D. discusses why remote patient monitoring and other at-home digital health innovations are becoming...
The Future of Telehealth and Technology Supporting It
Glooko CEO Russ Johannesson discusses the different interpretations of telehealth, the rapid development and adoption of telehealth during COVID-19 and...
Terumo, Glooko partner for diabetes data sharing with insulin patch pump
Terumo and Glooko announced a collaboration to integrate their technologies and create new diabetes data sharing solutions.
Exec Chat: Glooko CEO Talks Differentiation, Collaboration & The Future Of Digital Diabetes Solutions
Glooko CEO Russ Johannesson discusses the company’s connected diabetes care strategy, including its recent agreement with Johns Hopkins HealthCare Solutions...
Glooko picks up DIABNEXT to launch digital diabetes management platform in France
In its second acquisition of 2022 so far, Glooko is forging ahead in its mission not only to bulk up its digital diabetes management offerings but also...
M&A, Data & Big Approvals Are Defining Diabetes Tech in 2022
Glooko is the latest newsmaker for diabetes tech – as the company is quickly hopping back on the M&A trail after the xBird deal in February. Glooko...
Glooko acquires fellow diabetes management company DIABNEXT
Digital diabetes management company Glooko has acquired Paris-based DIABNEXT, a fellow diabetes care platform.
Glooko acquires DIABNEXT and its digital health platform for managing diabetes
Glooko announced that it acquired DIABNEXT, a developer of a digital health platform for managing diabetes and connecting to healthcare providers.
A proliferation of partnerships for platform plays
Glooko acquires xbird, a company developing AI-driven just in time adaptive interventions.
Glooko’s CEO expects to provide more personalized recommendations to users following German AI acquisition
Digital health company Glooko acquired xbird, a medical AI company with Just In Time Adaptive Intervention technologies to predict patient behavior and...
Glooko adds AI to its digital diabetes tools with xbird takeover
Glooko has made a name for itself in digital health circles with its data management tools for diabetes patients and has now added artificial intelligence...
Glooko acquires AI-enabled diabetes management company xbird
Digital diabetes and chronic condition management company Glooko announced it had acquired Berlin-based xbird, maker of AI-based diabetes care tools.
Glooko adds AI-powered coaching to its digital diabetes management tools with Xbird acquisition
Adding Xbird’s machine learning software will help the Glooko platform better predict patients’ behavior and improve how they manage their diabetes...
Glooko Keeps Diabetes Management Space Hot with M&A
Glooko is dipping into the field of artificial intelligence and machine learning with its acquisition of xbird.
Cardiometabolic Syndrome: Overlooked & Poised to Boom as Digital Tech Peaks
At Biotech Showcase 2022, Glooko COO Komathi Stem discussed how real world data, digital platforms and AI help pharmaceutical companies create therapies...
How Interoperability, Increased Reimbursement Options Will Drive Digital Health In 2022
Glooko CEO Russ Johannesson predicts that the growth in digital health funding will continue in 2022, and that the push toward interoperability will be...
Interoperability Is ‘Critical’ To Making Digital Health Tools More Valuable In 2022
Russ Johannesson, CEO of diabetes management company Glooko, looks back on the trends in digital health last year—including the explosion of funding—and...
Continuous Glucose Monitoring: How It’s Advancing Diabetes Care
Glooko was included in a report that highlights the burgeoning industry of continuous glucose monitoring and where it’s likely to head next.
Diabetes Digital Therapeutics for Healthcare Payers — ESP Vendor Matrix
Glooko was named a leader in diabetes digital therapeutics for healthcare payers by CB Insights. The ranking reinforces the company’s commitment...
How Technologies Are Personalizing At-Home Diabetes Care
Seemingly overnight, healthcare discovered and fully embraced digital health solutions. Just months after the 2020 nationwide lockdown, telehealth visits,...
Remote Patient Monitoring: A Platform for Innovations in Interdisciplinary Care Management
The aftershocks of COVID-19 continue to reverberate throughout the U.S. healthcare system. For example, the pandemic has forever dispelled the quaint notion...
Commercializing Digital Therapeutic Solutions: Key Lessons Learned to Watch
The pandemic has set ablaze the white-hot market for Digital Therapeutics (DTx), which “deliver medical interventions directly to patients using evidence-based,...
Misconceptions and Truths about Remote Patient Monitoring
In recent years, there has been a great deal of talk in healthcare circles about remote patient monitoring (RPM), a trend that has only accelerated over...
Glooko’s Remote Patient Monitoring for People with Diabetes
In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Russ Johannesson,...
ADA 2021 Study Outlines Benefits of RPM on Glycemic Control in Patients with Type 2 Diabetes
A study assessing use of remote patient monitoring in patients with type 2 diabetes outlines the impact continued participation in digital monitoring programs...
ADA21: Glooko Study Finds Diabetes Remote Monitoring Helps Keep Glucose Levels in Check
According to study findings presented by Glooko at the American Diabetes Association (ADA) scientific sessions on Friday, remote patient monitoring (RPM)...
Lilly inks smart insulin pen deals with Roche, Dexcom and more
The company aims to secure a CE mark for the Tempo Smart Button by the end of this year, enabling it and the Tempo Pen to be sold as a single package in...
Glooko, Eli Lilly to Collaborate on Connected Insulin Pens
Glooko will partner with Eli Lilly for a strategic digital health collaboration using Eli Lilly’s connected insulin pens, the Tempo Pen and Tempo Smart...
Russ Johannesson on Setting the Pace in Digital Health
To make sure its upcoming connected insulin pen system will work with the user’s choice of daily diabetes management platforms, Eli Lilly & Co. has...
The Modernization of Clinical Trials: COVID-19’s Lasting Impact
In 2015, the Clinical Trial Transformation Initiative (CTTI) recommended that trial sponsors consider fully or partially decentralized DCTs, defined as...
Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19
As with so many aspects of our daily lives, the impact of the COVID-19 pandemic on clinical trials was both widespread and monumental. Thousands of trials—an...
How Glooko improves health outcomes by connecting people with diabetes and obesity and their healthcare professionals, enabling telehealth, clinical research, and better collaboration! Interview with Zach Henderson, Chief Commercial Officer at Glooko
COVID-19 has changed the way healthcare is delivered and has rapidly affected the virtual care adoption and usage. To manage better their day-to-day routine...
The startup behind a COVID-19 vaccine gears up for an IPO
The pandemic has turned lesser-known biopharmaceutical startups into household names, including vaccine developers Moderna and BioNTech. Now the company...
Diabetes management startup Glooko collects $30M to push remote monitoring, new therapy areas
Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, announced today a $30 million Series D funding round led by Health...
Investors Ride High on the Telehealth Wave
One of the growing trends in the medtech industry is the rapid adoption of remote patient monitoring/telehealth. Glooko’s latest financing round is an...
The COVID-19 effect: Research platforms require new capabilities
With a shift to virtual/decentralized clinical trials, the popularity of decentralized clinical trials (DCTs) skyrocketed following the nationwide lockdown...
2021: Technology Trends and the Future of Medical Devices
While the far-reaching effects of COVID-19 have introduced the world to a “new normal,” the greatest impact has been in healthcare. In the long term,...
Exec Chat: How Glooko Plans To Ride Digital Health Care Wave To Profitability
In an interview with Medtech Insight, Glooko CEO Russ Johannesson outlines the company’s growth opportunities, expansion plans beyond diabetes and financing...
Life science companies combine to form COVID-19 research database
A group of major CRO, life science, data analytics, publishing and healthcare companies, including Glooko, joined forces to release a pro bono research...
Glooko collaborates with Association of British Clinical Diabetologists on education programme
US-based diabetes software app, Glooko has announced a partnership with the Association of British Clinical Diabetologists (ABCD) / Diabetes Technology...
Healthcare professionals offered free remote software to aid diabetes community
A leading diabetes software company is taking action to serve the global diabetes community amid the current COVID-19 pandemic and offering a free, remote...
Remote Care, Easy Refills Help People with Diabetes During COVID-19
As America and the rest of the world grapples with the escalating global coronavirus pandemic of 2020, healthcare providers are transitioning to remote...
Glooko’s newest executives, Aetion’s cross-industry data expert and more digital health hires
Digital diabetes management company Glooko has announced the appointments of a new CCO and COO. The first role went to Zach Henderson, formerly of LexisNexis...
Glooko Appoints Dr. Mark Clements as Chief Medical Officer
Glooko, a provider of diabetes data management solutions, announced the appointment of Mark Clements, MD, Ph.D., CPI, FAAP, as Chief Medical Officer. Dr....
Glooko partners with T1D Exchange
Glooko’s diabetes management platform will be used to incorporate data from devices like insulin pumps, CGMs and glucometers into the T1D Exchange...
